The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - LAUNXP Biomedical
Leadership - LAUNXP Biomedical
Stock and Other Ownership Interests - LAUNXP Biomedical
Consulting or Advisory Role - LAUNXP Biomedical
Research Funding - LAUNXP Biomedical
Patents, Royalties, Other Intellectual Property - LAUNXP Biomedical Co., Ltd

A proof-of-concept study of LXP5268 as an add-on neoadjuvant chemotherapy in patients with early-stage triple-negative breast cancer.
 
Liang Chih Liu
Research Funding - LAUNXP Biomedical
 
Tzong-Der Way
No Relationships to Disclose
 
Chin-Hua Lin
No Relationships to Disclose
 
Ya-Hui Chen
No Relationships to Disclose
 
Pin-Hung Kuo
No Relationships to Disclose
 
Chung-Hsin Tseng
No Relationships to Disclose
 
Chiu-Heng Chen
No Relationships to Disclose